M&A / Deals Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion Big Molecule WatchOn April 22, 2026 Amneal Pharmaceuticals, Inc.Read full story pharminent May 4, 2026 (Last updated: May 5, 2026) Big Molecule Watch On April 22, 2026 Amneal Pharmaceuticals, Inc. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: UCB Enters $2.2 Billion Deal to Acquire Candid TherapeuticsNext: Cytospire hauls in $83M for a new type of T cell engager Related Stories M&A / Deals Gilead inks $140M API supply deal, tightening ties to Korean manufacturer pharminent May 22, 2026 M&A / Deals GBL joins CVC in 10.7bn takeover bid for Recordati pharminent May 22, 2026 M&A / Deals Gilead Sciences completes Tubulis acquisition for $5bn pharminent May 22, 2026
